The Crosstalk of Endoplasmic Reticulum (ER) Stress Pathways with NF-κB: Complex Mechanisms Relevant for Cancer, Inflammation and Infection

M. Lienhard Schmitz,M. Samer Shaban,B. Vincent Albert,Anke Gökçen,Michael Kracht,M. Schmitz,M. Shaban,B. Albert
DOI: https://doi.org/10.3390/biomedicines6020058
IF: 4.757
2018-05-16
Biomedicines
Abstract:Stressful conditions occuring during cancer, inflammation or infection activate adaptive responses that are controlled by the unfolded protein response (UPR) and the nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB) signaling pathway. These systems can be triggered by chemical compounds but also by cytokines, toll-like receptor ligands, nucleic acids, lipids, bacteria and viruses. Despite representing unique signaling cascades, new data indicate that the UPR and NF-κB pathways converge within the nucleus through ten major transcription factors (TFs), namely activating transcription factor (ATF)4, ATF3, CCAAT/enhancer-binding protein (CEBP) homologous protein (CHOP), X-box-binding protein (XBP)1, ATF6α and the five NF-κB subunits. The combinatorial occupancy of numerous genomic regions (enhancers and promoters) coordinates the transcriptional activation or repression of hundreds of genes that collectively determine the balance between metabolic and inflammatory phenotypes and the extent of apoptosis and autophagy or repair of cell damage and survival. Here, we also discuss results from genetic experiments and chemical activators of endoplasmic reticulum (ER) stress that suggest a link to the cytosolic inhibitor of NF-κB (IκB)α degradation pathway. These data show that the UPR affects this major control point of NF-κB activation through several mechanisms. Taken together, available evidence indicates that the UPR and NF-κB interact at multiple levels. This crosstalk provides ample opportunities to fine-tune cellular stress responses and could also be exploited therapeutically in the future.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the interaction mechanism between the endoplasmic reticulum (ER) stress response pathway and the NF - κB signaling pathway, especially under pathological conditions such as cancer, inflammation and infection. Specifically, the article mainly focuses on the following points: 1. **Interaction between ER stress response (UPR) and NF - κB pathway**: - The paper discusses in detail how the unfolded protein response (UPR) and the NF - κB signaling pathway work together and their crosstalk under cell stress conditions, such as cancer, inflammation or infection. These pathways can be triggered by various factors such as chemicals, cytokines, Toll - like receptor ligands, nucleic acids, lipids, bacteria and viruses. 2. **Regulation by common transcription factors**: - New data show that the UPR and NF - κB pathways converge in the nucleus through ten major transcription factors (TFs), including activating transcription factor (ATF) 4, ATF3, CCAAT/enhancer - binding protein (CEBP) homologous protein (CHOP), X - box - binding protein (XBP) 1, ATF6α and five NF - κB subunits. Combinations of these transcription factors occupy multiple genomic regions (enhancers and promoters) and coordinate the transcriptional activation or inhibition of hundreds of genes, thus determining the balance between metabolic and inflammatory phenotypes, as well as the degree of apoptosis and autophagy or cell damage repair and survival. 3. **Effect of ER stress on NF - κB activation**: - The authors also discuss the results of genetic experiments and chemical activators, indicating that ER stress may regulate the activation of NF - κB by affecting the degradation pathway of the cytoplasmic NF - κB inhibitor IκBα. For example, PERK phosphorylates eIF2α, inhibits the synthesis of IκBα, and thus indirectly activates NF - κB. 4. **Potential therapeutic applications**: - These findings not only reveal the complex interaction mechanism between UPR and NF - κB, but also provide a theoretical basis for the future development of therapeutic methods targeting these pathways. In particular, understanding how these two pathways regulate each other can provide new strategies for treating cancer, inflammation and infection. In summary, this paper aims to deeply explore the complex interaction between the ER stress response and the NF - κB signaling pathway, especially the molecular mechanism under pathological conditions, and provide a theoretical basis for future therapeutic research.